These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1159819)
1. Activation of carcinogenic arylhydroxamic acids by human tissues. King CM; Olive CW; Cardona RA J Natl Cancer Inst; 1975 Aug; 55(2):285-7. PubMed ID: 1159819 [TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of arylhydroxamic acids by N-O-acyltransferase of rat mammary gland. King CM; Traub NR; Lortz ZM; Thissen MR Cancer Res; 1979 Sep; 39(9):3369-72. PubMed ID: 476668 [TBL] [Abstract][Full Text] [Related]
3. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases. Flammang TJ; Kadlubar FF Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755 [TBL] [Abstract][Full Text] [Related]
4. Evidence for a second arylhydroxamic acid acyltransferase species in the small intestine of the rat. Olive CW; King CM Chem Biol Interact; 1975 Dec; 11(6):599-604. PubMed ID: 1201619 [TBL] [Abstract][Full Text] [Related]
5. Irradiation-induced adduct formation of RNA with carcinogenic arylamine derivatives. Cardona RA; King CM; Redpath JL Cancer Res; 1975 Aug; 35(8):2007-14. PubMed ID: 1149020 [TBL] [Abstract][Full Text] [Related]
6. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium. Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386 [No Abstract] [Full Text] [Related]
7. Relationship of metabolic activation of N-hydroxy-N-acylarylamines to biological response in the liver and mammary gland of the female CD rat. Shirai T; Fysh JM; Lee MS; Vaught JB; King CM Cancer Res; 1981 Nov; 41(11 Pt 1):4346-53. PubMed ID: 6118207 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of strain, species, and sex on the acyltransferase- and sulfotransferase-catalyzed activations of N-hydroxy-N-2-fluorenylacetamide. King CM; Olive CW Cancer Res; 1975 Apr; 35(4):906-12. PubMed ID: 803872 [TBL] [Abstract][Full Text] [Related]
9. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles. Yost Y; Gutmann HR; Rydell RE Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807 [TBL] [Abstract][Full Text] [Related]
10. Reductase activity of aldehyde oxidase toward the carcinogen N-hydroxy-2-acetylaminofluorene and the related hydroxamic acids. Kitamura S; Sugihara K; Tatsumi K Biochem Mol Biol Int; 1994 Dec; 34(6):1197-203. PubMed ID: 7696992 [TBL] [Abstract][Full Text] [Related]
11. Comparative adduct formation of 4-aminobiphenyl and 2-aminofluorene derivatives with macromolecules of isolated liver parenchymal cells. King CM; Traub NR; Cardona RA; Howard RB Cancer Res; 1976 Jul; 36(7 PT 1):2374-81. PubMed ID: 1277141 [TBL] [Abstract][Full Text] [Related]
12. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol. Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998 [TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184 [TBL] [Abstract][Full Text] [Related]
14. Induction of DNA repair synthesis in human urothelial cells by the N-hydroxy metabolites of carcinogenic arylamines. Wang CY; Christensen B; Zukowski K; Morton KC; Lee MS J Natl Cancer Inst; 1984 Apr; 72(4):847-52. PubMed ID: 6584661 [TBL] [Abstract][Full Text] [Related]
15. Activation of the O-glucuronide of the carcinogen N-hydroxy-N-2-fluorenylacetamide by enzymatic deacetylation in vitro: formation of fluorenylamine-tRNA adducts. Cardona RA; King CM Biochem Pharmacol; 1976 May; 25(9):1051-6. PubMed ID: 5097 [No Abstract] [Full Text] [Related]
16. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation. Allaben WT; Weeks CE; Weis CC; Burger GT; King CM Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466 [TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes. Smith TJ; Hanna PE Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051 [TBL] [Abstract][Full Text] [Related]
18. DNA adducts formed from the probable proximate carcinogen, N-hydroxy-3,2' -dimethyl-4-aminobiphenyl, by acid catalysis or S-acetyl coenzyme A-dependent enzymatic esterification. Flammang TJ; Westra JG; Kadlubar FF; Beland FA Carcinogenesis; 1985 Feb; 6(2):251-8. PubMed ID: 3971490 [TBL] [Abstract][Full Text] [Related]
19. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase. Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236 [TBL] [Abstract][Full Text] [Related]
20. Activatin of guanylate cyclase during the oxidation of arylamine carcinogens. DeRubertis FR; Craven PA Biochem Biophys Res Commun; 1979 Jul; 89(2):464-73. PubMed ID: 39558 [No Abstract] [Full Text] [Related] [Next] [New Search]